Document Detail

Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome.
MedLine Citation:
PMID:  17850735     Owner:  NLM     Status:  MEDLINE    
Low-density lipoprotein cholesterol (LDL-C) is the primary target of lipid-lowering therapy. However, all lipoproteins containing apolipoprotein B (apo B) appear to be atherogenic. Preferred targets of therapy therefore may include either the cholesterol in all apo B-containing lipoproteins (non-high-density lipoprotein cholesterol [non-HDL-C]) or total apo B itself. Apo B can be measured by three methods: chemically, by nuclear magnetic resonance (NMR), and by immunoassay. This study compares the first two methods as a function of the number of metabolic risk factors in patients with metabolic syndrome. Plasma lipid, lipoprotein cholesterol, and apo B levels were measured in 274 adults with varying numbers of metabolic syndrome components. Low-density lipoprotein (LDL) particle sizes were measured by gel electrophoresis and by NMR. Total apo B was estimated chemically and by conversion of NMR lipoprotein particle number, assuming one apo B molecule per lipoprotein particle. As the number of metabolic syndrome components increased, apo B rose by both chemical and NMR methods, but by chemical methods, increases were in the triglyceride-rich fraction, whereas by NMR, they were in LDL. The correlation between total apo B measured by the two methods was only moderate (r = .73). Further, non-HDL-C was more highly correlated with total apo B measured chemically than either LDL-C or total apo B by NMR. Non-HDL-C correlates highly with total apo B in patients with metabolic syndrome and had advantages as a target of therapy over LDL-C or NMR apo B.
Jacob J Clarenbach; Scott M Grundy; Natalia Palacio; Gloria Lena Vega
Related Documents :
2751745 - Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
1742325 - Apo b metabolism in the cynomolgus monkey: evidence for post-transcriptional regulation.
1931875 - The effect of fasting triacylglyceride concentration and apolipoprotein e polymorphism ...
15161775 - Effect of apolipoprotein e4 allele on plasma ldl cholesterol response to diet therapy i...
12109735 - Organochlorine concentrations in the saimaa ringed seal (phoca hispida saimensis) from ...
11709015 - Murine high-fat diet and laser photochemical model of basal deposits in bruch membrane.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of investigative medicine : the official publication of the American Federation for Clinical Research     Volume:  55     ISSN:  1081-5589     ISO Abbreviation:  J. Investig. Med.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-09-13     Completed Date:  2007-11-02     Revised Date:  2007-11-30    
Medline Journal Info:
Nlm Unique ID:  9501229     Medline TA:  J Investig Med     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  237-47     Citation Subset:  IM    
Center for Human Nutrition, the Donald W Reynolds Cardiovascular Research Center of the University of Texas Southwestern Medical Center at Dallas, TX 75390-9052, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apolipoproteins B / blood*
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Lipoproteins, HDL / blood
Magnetic Resonance Spectroscopy
Metabolic Syndrome X / blood,  etiology*
Middle Aged
Particle Size
Risk Factors
Reg. No./Substance:
0/Apolipoproteins B; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Lipoproteins, HDL; 0/very high density lipoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with ...
Next Document:  Catabolism of glycoconjugates in chronic otitis media with cholesteatoma.